Request Demo
Pharmaceutical Insights
Navigate pharmaceutical trends with our insights on targets, institutional pipelines, clinical advances, and new drugs.
Recent blog posts
Latest Hotspot
8 min read
CCR2 2026 Target Evaluation Report: Biology, Validation, Competition, IP, and R&D Strategy
14 July 2026
A visual target evaluation report for CCR2, generated in a PatSnap Life Sciences MCP-style workflow covering biology, validation evidence, clinical competition, IP signals, and R&D strategy.
Latest Hotspot
8 min read
CXCR2 2026 Target Evaluation Report: Biology, Validation, Competition, IP, and R&D Strategy
14 July 2026
A visual target evaluation report for CXCR2, generated in a PatSnap Life Sciences MCP-style workflow covering biology, validation evidence, clinical competition, IP signals, and R&D strategy.
Latest Hotspot
8 min read
CXCR1 2026 Target Evaluation Report: Biology, Validation, Competition, IP, and R&D Strategy
14 July 2026
A visual target evaluation report for CXCR1, generated in a PatSnap Life Sciences MCP-style workflow covering biology, validation evidence, clinical competition, IP signals, and R&D strategy.
Latest Hotspot
8 min read
CXCL8 2026 Target Evaluation Report: Biology, Validation, Competition, IP, and R&D Strategy
14 July 2026
A visual target evaluation report for CXCL8, generated in a PatSnap Life Sciences MCP-style workflow covering biology, validation evidence, clinical competition, IP signals, and R&D strategy.
Latest Hotspot
8 min read
IFNGR1 2026 Target Evaluation Report: Biology, Validation, Competition, IP, and R&D Strategy
14 July 2026
A visual target evaluation report for IFNGR1, generated in a PatSnap Life Sciences MCP-style workflow covering biology, validation evidence, clinical competition, IP signals, and R&D strategy.
Latest Hotspot
8 min read
IFNAR1 2026 Target Evaluation Report: Biology, Validation, Competition, IP, and R&D Strategy
14 July 2026
A visual target evaluation report for IFNAR1, generated in a PatSnap Life Sciences MCP-style workflow covering biology, validation evidence, clinical competition, IP signals, and R&D strategy.
Latest Hotspot
8 min read
IFNG 2026 Target Evaluation Report: Biology, Validation, Competition, IP, and R&D Strategy
14 July 2026
A visual target evaluation report for IFNG, generated in a PatSnap Life Sciences MCP-style workflow covering biology, validation evidence, clinical competition, IP signals, and R&D strategy.
Latest Hotspot
8 min read
CASP1 2026 Target Evaluation Report: Biology, Validation, Competition, IP, and R&D Strategy
14 July 2026
A visual target evaluation report for CASP1, generated in a PatSnap Life Sciences MCP-style workflow covering biology, validation evidence, clinical competition, IP signals, and R&D strategy.
Latest Hotspot
8 min read
NLRP3 2026 Target Evaluation Report: Biology, Validation, Competition, IP, and R&D Strategy
14 July 2026
A visual target evaluation report for NLRP3, generated in a PatSnap Life Sciences MCP-style workflow covering biology, validation evidence, clinical competition, IP signals, and R&D strategy.
Latest Hotspot
8 min read
IL1R1 2026 Target Evaluation Report: Biology, Validation, Competition, IP, and R&D Strategy
14 July 2026
A visual target evaluation report for IL1R1, generated in a PatSnap Life Sciences MCP-style workflow covering biology, validation evidence, clinical competition, IP signals, and R&D strategy.
Latest Hotspot
8 min read
IL1B 2026 Target Evaluation Report: Biology, Validation, Competition, IP, and R&D Strategy
14 July 2026
A visual target evaluation report for IL1B, generated in a PatSnap Life Sciences MCP-style workflow covering biology, validation evidence, clinical competition, IP signals, and R&D strategy.
Latest Hotspot
8 min read
TNFRSF1A 2026 Target Evaluation Report: Biology, Validation, Competition, IP, and R&D Strategy
14 July 2026
A visual target evaluation report for TNFRSF1A, generated in a PatSnap Life Sciences MCP-style workflow covering biology, validation evidence, clinical competition, IP signals, and R&D strategy.